Monoclonal Antibody of 100 μg targeting Rb for IHC, IP, WB.
| Product Specifications | |
| Application | IP, WB, IHC |
| Reactivity | Human |
| Clonality | Monoclonal IgG2a ĸ |
| Host | Mouse |
| Immunogen | Recombinant human Rb (612-928 a.a.) |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | 100 μg IgG in 100 μl PBS containing 50% glycerol, pH 7.2. Contains no preservatives. |
| Citations for Anti-Rb (Human) mAb (Clone: 3H9) – 3 Found |
| Miyazaki, Makoto; Otomo, Ryo; Matsushima-Hibiya, Yuko; Suzuki, Hidenobu; Nakajima, Ayana; Abe, Naomi; Tomiyama, Arata; Ichimura, Koichi; Matsuda, Koichi; Watanabe, Toshiki; Ochiya, Takahiro; Nakagama, Hitoshi; Sakai, Ryuichi; Enari, Masato. The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas. Cell Death Discovery. 4:56. PubMed - Comments: Used in: WB |
| Yanagihara, Kazuyoshi; Kubo, Takanori; Iino, Yuki; Mihara, Keichiro; Morimoto, Chie; Seyama, Toshio; Kuwata, Takeshi; Ochiai, Atsushi; Yokozaki, Hiroshi. Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line. Oncotarget. 2019;10(25):2435-2450. PubMed - Comments: Used in: IHC |
| Tanaka, Hiroki; Hijioka, Susumu; Hosoda, Waki; Ueno, Makoto; Kobayashi, Noritoshi; Ikeda, Masafumi; Ito, Tetsuhide; Kodama, Yuzo; Morizane, Chigusa; Notohara, Kenji; Taguchi, Hiroki; Kitano, Masayuki; Komoto, Izumi; Tsuji, Akihito; Hashigo, Syunpei; Kanno, Atsushi; Miyabe, Katsuyuki; Takagi, Tadayuki; Ishii, Hiroshi; Kojima, Yasushi; Yoshitomi, Hideyuki; Yanagimoto, Hiroaki; Furuse, Junji; Mizuno, Nobumasa. Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups. Pancreatology : Official Journal Of The International Association Of Pancreatology (Iap) ... [Et Al.]. 2020;20(7):1421-1427. PubMed - Comments: Used in: IHC |